Ardian Completes $47 Million Financing Led by Medtronic to Develop Hypertension Treatment

Ardian, Inc., developer of a breakthrough catheter-based medical device to treat hypertension, announced today that Medtronic, Inc., one of the world’s leading medical technology companies, has led a $47 million financing of the company.

Following a period of yielding results and unpleasant decisions, things are now moving in the right direction for Coloplast.

In the first quarter, Coloplast achieved an organic growth rate of 6% and an operating profit margin of 15%. If exchange rates had not been unfavourable to Coloplast, the operating profit margin would have been 17% against 16% for the same period last year.